Introduction
Adiponectin, a 244-amino acid protein encoded by the apM1 gene, is primarily produced by adipose cells (hence, an adipokine). Structurally, it belongs to the soluble defense collagen superfamily, featuring a collagen-like domain similar to collagen VIII, X, and complement factor C1q-like globular domain. Adiponectin monomers assemble into homotrimers, serving as the foundation for higher-order complexes found circulating in serum.
Description
Recombinant human Acrp30, expressed in HEK293 cells, is engineered with a FLAG tag.
Biological Activity
The ability of mammalian cell-derived human Adiponectin to suppress glucose production was assessed using an in vitro gluconeogenesis assay with primary hepatocytes. The half-maximal effective concentration (ED50) was determined to be approximately 6 micrograms per milliliter.
Physical Appearance
Lyophilized powder, white in color.
Formulation
Prior to lyophilization, the product undergoes filtration (0.4 micrometers) and is prepared in a 50mM phosphate buffer containing 75mM NaCl at pH 7.4, with a concentration of 0.5 milligrams per milliliter.
Solubility
To generate a working stock solution of roughly 0.5 milligrams per milliliter, reconstitute the lyophilized pellet with deionized water, ensuring complete dissolution. This product is not sterile; for cell culture applications, it requires filtration using an appropriate sterile filter.
Stability
For long-term storage, keep lyophilized AdipoQ at -20 degrees Celsius. After reconstitution, aliquot the product to prevent repeated freeze-thaw cycles. Reconstituted protein exhibits stability at 4 degrees Celsius for a limited duration, showing no noticeable changes for up to two weeks. The lyophilized protein remains stable for 24 months when stored at -20 degrees Celsius.
Purity
High-performance liquid chromatography (HPLC) and SDS-PAGE analysis confirm a purity exceeding 98%.
Synonyms
Acrp30, AdipoQ, GBP-28, APM-1, ACDC.
Source
HEK293 (Human Embryonic Kidney cell line).
Amino Acid Sequence
ETTTQGPGVL LPLPKGACTG WMAGIPGHPG HNGAPGRDGR DGTPGEKGEK GDPGLIGPKG DIGETGVPGA EGPRGFPGIQ GRKGEPGEGA YVYRSAFSVG LETYVTIPNM PIRFTKIFYN QQNHYDGSTG KFHCNIPGLY YFAYHIVYMK DVKVSLFKKD KAMLFTYDQY QENNVDQASG SVLLHLEVGD QVWLQVYGEG ERNGLYADND NDSTFTGFLL YHDTNDYKDDDDK.